Erschienen in:
Open Access
09.05.2019 | Original Article
Concomitant Use of Hyaluronic Acid and Laser
in Facial Rejuvenation
verfasst von:
Fernando Urdiales-Gálvez, Sandra Martín-Sánchez, Mónica Maíz-Jiménez, Antonio Castellano-Miralla, Leonardo Lionetti-Leone
Erschienen in:
Aesthetic Plastic Surgery
|
Ausgabe 4/2019
Einloggen, um Zugang zu erhalten
Abstract
Background
Facial aging is a process that involves many different changes.
Therefore, in many patients, it may be necessary to perform a combined
treatment. Botulinum toxin A and dermal fillers are the two most popular
nonsurgical cosmetic procedures performed globally to treat age-associated
changes. However, there are not many studies reporting the concomitant use of
dermal fillers and laser technology for facial rejuvenation. This review aims to
assess the concomitant use of dermal hyaluronic acid (HA) fillers and laser
technology for facial rejuvenation.
Methods
The present updated consensus recommendations are based on the
experience and opinions of the authors and on a literature search.
Results
If a combined procedure (HA and light treatments) is to be
performed, on the same day, the panel recommends starting always with the light
treatments, avoiding skin manipulations after having injected HA. To customize
the therapeutic management, it is crucial to establish a precise diagnosis of
the photodamage and loss of volumes suffered by the patients.
Conclusions
The currently available scientific evidence about the combined use
of HA fillers and laser–radiofrequency–intense pulsed light (laser/RF/IPL) is
limited and encompasses mainly small and nonrandomized studies. Nevertheless,
most of these studies found that, on average, the concomitant use (same day) of
laser and HA fillers for facial rejuvenation represents an effective and safe
strategy which improves clinical results and patient’s satisfaction. Future
well-designed clinical studies are needed regarding the effectiveness and safety
of combination filler/laser treatments.
Level of Evidence IV
This journal requires that authors assign a level of evidence to
each article. For a full description of these Evidence-Based Medicine ratings,
please refer to the Table of Contents or the online Instructions to Authors
www.springer.com/00266.